Cancer Research Cell Death Mechanisms and Cancer Therapy  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rios-Doria, J.
Right arrow Articles by Day, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rios-Doria, J.
Right arrow Articles by Day, M. L.
[Cancer Research 64, 7237-7240, October 15, 2004]
© 2004 American Association for Cancer Research


Advances in Brief

Cleavage of ß-Catenin by Calpain in Prostate and Mammary Tumor Cells

Jonathan Rios-Doria1, Rainer Kuefer5, Stephen P. Ethier4 and Mark L. Day1,2,3,4

1 Cellular and Molecular Biology Graduate Program, 2 Department of Urology, 3 Michigan Urology Center, 4 Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan; and the 5 Department of Urology, University of Ulm, Ulm, Germany

Mutations in the NH2-terminal regulatory domain of the ß-catenin gene lead to aberrant stabilization and accumulation of the protein and increased TCF/LEF-dependent transcription. Although these mutations are common in some cancers, they are infrequent in prostate and breast cancer. We have found that metastatic prostate cancer specimens, obtained through a rapid autopsy tissue procurement program, expressed a novel Mr 75,000 proteolytic fragment of ß-catenin (ß-cat75). ß-Cat75 was also expressed in multiple prostate and breast cancer cell lines and was closely associated with the activity of the calcium-dependent protease, calpain. In a prostate cancer cDNA microarray, m-calpain RNA levels were found to be significantly increased in metastatic disease compared with normal prostate. We showed calpain-dependent generation of ß-cat75 in cell culture and in vitro. Molecular mapping revealed that calpain cleavage removed the NH2-terminal regulatory domain of the ß-catenin protein. Treatment of MCF-7 cells with ionomycin led to increased accumulation of ß-cat75 in the nucleus and TCF-dependent transcriptional activity. Overexpression of a similar ß-catenin fragment that lacks the NH2-terminal 132 amino acids and has transforming potential activated TCF-dependent transcription. Given the low frequency of mutation-induced activation of ß-catenin in prostate and breast cancers, proteolytic cleavage of ß-catenin by calpain may represent a novel mechanism by which the protein is activated during tumorigenesis.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Osman, V. Gobert, F. Ponthan, O. Heidenreich, M. Haenlin, and L. Waltzer
A Drosophila model identifies calpains as modulators of the human leukemogenic fusion protein AML1-ETO
PNAS, July 21, 2009; 106(29): 12043 - 12048.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. T. Read, M. Rahmani, S. Boroomand, S. Allahverdian, B. M. McManus, and P. S. Rennie
Androgen Receptor Regulation of the Versican Gene through an Androgen Response Element in the Proximal Promoter
J. Biol. Chem., November 2, 2007; 282(44): 31954 - 31963.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. P. Pelley, K. Chinnakannu, S. Murthy, F. M. Strickland, M. Menon, Q. P. Dou, E. R. Barrack, and G. P.-V. Reddy
Calmodulin-Androgen Receptor (AR) Interaction: Calcium-Dependent, Calpain-Mediated Breakdown of AR in LNCaP Prostate Cancer Cells
Cancer Res., December 15, 2006; 66(24): 11754 - 11762.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Helfer, B. C. Boswell, D. Finlay, A. Cipres, K. Vuori, T. Bong Kang, D. Wallach, A. Dorfleutner, J. M. Lahti, D. C. Flynn, et al.
Caspase-8 Promotes Cell Motility and Calpain Activity under Nonapoptotic Conditions.
Cancer Res., April 15, 2006; 66(8): 4273 - 4278.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. J. Mulholland, S. Dedhar, G. A. Coetzee, and C. C. Nelson
Interaction of Nuclear Receptors with the Wnt/{beta}-Catenin/Tcf Signaling Axis: Wnt You Like to Know?
Endocr. Rev., December 1, 2005; 26(7): 898 - 915.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. J. Libertini, B. S. Robinson, N. K. Dhillon, D. Glick, M. George, S. Dandekar, J. P. Gregg, E. Sawai, and M. Mudryj
Cyclin E Both Regulates and Is Regulated by Calpain 2, a Protease Associated with Metastatic Breast Cancer Phenotype
Cancer Res., December 1, 2005; 65(23): 10700 - 10708.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-N. Song and E. P. Gelmann
Interaction of {beta}-Catenin and TIF2/GRIP1 in Transcriptional Activation by the Androgen Receptor
J. Biol. Chem., November 11, 2005; 280(45): 37853 - 37867.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. J. Franco and A. Huttenlocher
Regulating cell migration: calpains make the cut
J. Cell Sci., September 1, 2005; 118(17): 3829 - 3838.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Benetti, T. Copetti, S. Dell'Orso, E. Melloni, C. Brancolini, M. Monte, and C. Schneider
The Calpain System Is Involved in the Constitutive Regulation of {beta}-Catenin Signaling Functions
J. Biol. Chem., June 10, 2005; 280(23): 22070 - 22080.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.